The pharmacomicrobiomics portal: A database for drug-microbiome interactions

Current Pharmacogenomics and Personalized Medicine

Volumn 10, Issue 3, 2012, Pages 195-203

  Rizkallah, Mariam R ^a,b   Gamal Eldin, Soha ^c   Saad, Rama ^b   Aziz, Ramy K ^c  

^a Information Technology Institute Giaz   (Egypt)

^b The American University in Cairo   (Egypt)

^c CAIRO UNIVERSITY   (Egypt)

Author keywords

Biocuration; Human microbiome research; Microbiota; Personalized medicine; Pharmacodynamics; Pharmacokinetics; Pharmacomicrobiomics; Relational database

Indexed keywords

AUTOMATION; BIOCHEMISTRY; COMPUTER; DATA BASE; DATA MINING; DRUG INTERACTION; DRUG MICROBIOME INTERACTION; INFORMATION PROCESSING; MICROBIOME; PHARMACOGENOMICS; PHARMACOMICROBIOMICS DATABASE; REVIEW; SEARCH ENGINE;

EID: 84867009591     PISSN: 18756921     EISSN: 18756913     Source Type: Journal    
DOI: 10.2174/187569212802510030     Document Type: Review

References (64)

1. Sadée W, Dai Z. Pharmacogenetics/genomics and personalized medicine. Hum Mol Genet 2005; 14(2): R207-R214.
2. Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature 2001; 409(6822): 860-921.
3. Venter JC, Adams MD, Myers EW, et al. The sequence of the human genome. Science 2001; 291(5507): 1304-1351.
4. Relman DA, Falkow S. The meaning and impact of the human genome sequence for microbiology. Trends Microbiol 2001; 9(5): 206-8.
5. Human Variome Project. Available from: http://www.humanvariomeproject.org/ [Accessed June 15, 2012]
6. Ring HZ, Kwok PY, Cotton RG. Human Variome Project: an international collaboration to catalogue human genetic variation. Pharmacogenomics 2006; 7(7): 969-972.
7. Anonymous (Editorial). What is the human variome project? Nat Genet 2007; 39(4): 423.
8. Cotton RG. Collection of variation causing disease--the Human Variome Project. Hum Genomics 2009; 3(4): 301-3.
9. Hamburg MA, Collins FS. The path to personalized medicine. N Engl J Med 2010; 363(4): 301-4.
10. Wadsworth C. The Pharmacogenomics Knowledge Base [PharmGKB]. Available from: http://www.pharmgkb.org/ [Accessed July 3, 2012]
11. Owen RP, Altman RB, Klein TE. PharmGKB and the International Warfarin Pharmacogenetics Consortium: the changing role for pharmacogenomic databases and single-drug pharmacogenetics. Hum Mutat 2008; 29(4): 456-60.
12. The Pharmacogenetics and Cell Database. Available from: http://www.pacdb.org/. [Accessed June 15, 2012]
13. Gamazon ER, Duan S, Zhang W, et al. PACdb: a database for cellbased pharmacogenomics. Pharmacogenet Genomics 2010; 20(4): 269-73.
14. Peterson J, Garges S, Giovanni M, et al. The NIH Human Microbiome Project. Genome Res 2009; 19(12): 2317-23.
15. Van Houte J, Gibbons RJ. Studies of the cultivable flora of normal human feces. Antonie Van Leeuwenhoek 1966; 32(2): 212-22.
16. Whitman WB, Coleman DC, Wiebe WJ. Prokaryotes: the unseen majority. Proc Natl Acad Sci USA 1998; 95(12): 6578-83.
17. Rizkallah MR, Saad R, Aziz RK. The Human Microbiome Project, personalized medicine and the birth of pharmacomicrobiomics. Cur Pharmacog Personalized Med 2010; 8(3): 182-93.
18. Kinross JM, Darzi AW, Nicholson JK. Gut microbiomehost interactions in health and disease. Genome Med 2012; 3(3): 14.
19. Goldman P, Peppercorn MA, Goldin BR. Metabolism of drugs by microorganisms in the intestine. Am J Clin Nutr 1974; 27(11): 1348-55.
20. Peppercorn M, Goldman P. Drug bacteria interactions. Rev Drug Metab Drug Interactions 1976; 2: 75-88.
21. Goldman P. Biochemical pharmacology of the intestinal flora. Annu Rev Pharmacol Toxicol 1978; 18: 523-39.
22. Gingell R, Bridges JW, Williams RT. The role of the gut flora in the metabolism of prontosil and neoprontosil in the rat. Xenobiotica 1971; 1(2): 143-56.
23. Peppercorn MA, Goldman P. The role of intestinal bacteria in the metabolism of salicylazosulfapyridine. J Pharmacol Exp Ther 1972; 181(3): 555-62.
24. Peppercorn MA, Goldman P. Caffeic acid metabolism by gnotobiotic rats and their intestinal bacteria. Proc Natl Acad Sci USA 1972; 69(6): 1413-5.
25. Goldin BR, Peppercorn MA, Goldman P. Contributions of host and intestinal microflora in the metabolism of L-dopa by the rat. J Pharmacol Exp Ther 1973; 186(1): 160-6.
26. Sousa T, Paterson R, Moore V, et al. The gastrointestinal microbiota as a site for the biotransformation of drugs. Int J Pharm 2008; 363(1-2): 1-25.
27. Wilson ID, Nicholson JK. The role of gut microbiota in drug response. Curr Pharm Des 2009; 15(13): 1519-23.
28. Dobkin JF, Saha JR, Butler VP, Jr., et al. Inactivation of digoxin by Eubacterium lentum, an anaerobe of the human gut flora. Trans Assoc Am Physicians 1982; 95: 22-9.
29. Mathan VI, Wiederman J, Dobkin JF, et al. Geographic differences in digoxin inactivation, a metabolic activity of the human anaerobic gut flora. Gut 1989; 30(7): 971-7.
30. Davydov L, Yermolnik M, Cuni LJ. Warfarin and amoxicillin/ clavulanate drug interaction. Ann Pharmacother 2003; 37(3): 367-70.
31. O'Hara AM, Shanahan F. The gut flora as a forgotten organ. EMBO Rep 2006; 7(7): 688-93.
32. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 2012; 486(7402): 207-14.
33. Aziz RK, Saad R, Rizkallah MR. PharmacoMicrobiomics or how bugs modulate drugs: an educational initiative to explore the effects of human microbiome on drugs. BMC Bioinformatics 2011; 12(Suppl 7): A10.
34. MySQL. The world's most popular open source database. Available from: www.mysql.com/ [Accessed June 15, 2012]
35. Django {pipe} The Web framework for perfectionists with deadlines. Available from: https://www.djangoproject.com/ [Accessed June 15, 2012]
36. Arcsin Web Templates - Free CSS Templates & WordPress Themes. Available from: http://templates.arcsin.se/ [Accessed June 15, 2012]
37. JQuery: The Write Less, Do More, JavaScript Library. Available from: http://jquery.com/. [Accessed June 15, 2012]
38. Howe D, Costanzo M, Fey P, et al. Big data: The future of biocuration. Nature 2008; 455(7209): 47-50.
39. Sayers EW, Barrett T, Benson DA, et al. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res 2012; 40(Database issue): D13-25.
40. NCBI PubMed database. Available from: http://www.ncbi.nlm.nih.gov/pubmed [Accessed June 15, 2012]
41. The PubChem Project. Available from: http://pubchem.ncbi.nlm.nih.gov/ [Accessed July 3, 2012]
42. Bolton EE, Wang Y, Thiessen PA, et al. PubChem: integrated platform of small molecules and biological activities. Annu Rep Comput Chem 2008; 4: 217-241.
43. Wang Y, Xiao J, Suzek TO, et al. PubChem's BioAssay Database. Nucleic Acids Res 2012; 40(Database issue): D400-12.
44. The NCBI Taxonomy Homepage. Available from: http://www.ncbi.nlm.nih.gov/taxonomy [Accessed July 3, 2012]
45. The Comparative Toxicogenomics Database (CTD). Available from: http://ctdbase.org [Accessed July 3, 2012]
46. Davis AP, Murphy CG, Rosenstein MC, et al. The Comparative Toxicogenomics Database facilitates identification and understanding of chemical-gene-disease associations: arsenic as a case study. BMC Med Genomics 2008; 1: 48.
47. Overbeek R, Disz T, Stevens R. The SEED: a peer-to-peer environment for genome annotation. Commun ACM 2004; 47(11): 46-51.
48. Overbeek R, Begley T, Butler RM, et al. The subsystems approach to genome annotation and its use in the project to annotate 1000 genomes. Nucleic Acids Res 2005; 33(17): 5691-5702.
49. The SEED database. Available from: http://pubseed.theseed.org/seedviewer.cgi [Accessed June 10 2012]
50. KEGG: Kyoto Encyclopedia of Genes and Genomes. Available from: http://www.genome.jp/kegg/. [Accessed June 10, 2012]
51. Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000; 28(1): 27-30.
52. Kanehisa M, Goto S, Sato Y, et al. KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res 2012; 40(Database issue): D109-14.
53. WebFaction web hosting. Available from: http://www.webfaction.com/ [Accessed June 15, 2012]
54. DjangoFriendlyWebHosts - Django. Available from: https://code.djangoproject.com/wiki/DjangoFriendlyWebHosts [Accessed June 15, 2012]
55. PharmacoMicrobiomics: Free software downloads at Source Forge.net. Available from: http://sourceforge.net/projects/pharmacomicro/ [Accessed June 15, 2012]
56. The Django Book. Available from: http://www.djangobook.com/ [Accessed June 15, 2012]
57. PharmacoMicrobiomics literature. Available from: http://pharmacomicrobiomics.com/papers [Accessed June 11, 2012]
58. PharmacoMicrobiomics Wordpress Blog. Available from: http://pharmacomicrobiomics.wordpress.com/ [Accessed June 11, 2012]
59. PharmacoMicrobiomics: Drug-Microbiome Interactions {pipe} Mendeley Group. Available from: http://www.mendeley.com/groups/1578903/pharmacomicrobiomics-drug-microbiome-interactions/ [Accessed June 15, 2012]
60. PharmacoMicrobiomics Database's Mendeley profile. Available from: http://www.mendeley.com/profiles/pharmacomicrobiomicsdatabase/ [Accessed June 15, 2012]
61. PharmacoMicrobiomics (pharmacomicro) on Twitter. Available from: https://twitter.com/#!/PharmacoMicro [Accessed June 15, 2012]
62. Cock PJ, Antao T, Chang JT, et al. Biopython: freely available Python tools for computational molecular biology and bioinformatics. Bioinformatics 2009; 25(11): 1422-1423.
63. Chen R, Mias GI, Li-Pook-Than J, et al. Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell 2012; 148(6): 1293-1307.
64. Borenstein E. Computational systems biology and in silico modeling of the human microbiome. Brief Bioinform 2012 [Epub ahead of print]